5、o-treatsampleTreatmentreceivedsampleALND(n=420)SLNDOnly(n=436)ALND(n=388)SLNDonly(n=425)Locoregionalrecurrence15(3.6%)8(1.8%)16(4.1%)12(2.8%)localrecurrence13(3.1%)7(1.6%)14(3.6%)8(1.9%)regionalrecurrence2(0.5%)4(0.9%)2(0.5%)4(0.9%)2、ACOSOGZ0011局部区域复发Giuliano, A.E., et al., Locoregio
6、nal recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg, 2010. 252(3): p. 426-32; discussion 432-3.2、ACOSOGZ0011长期随访SLNB(+